NeoSync

NeoSync, Inc. is dedicated to the clinical development of innovative Transcranial Magnetic Stimulation (TMS) technologies for central nervous system disorders, including major depressive disorder. Headquartered in Boston, USA, the company boasts an experienced executive management team in the field of medical device development. Its proprietary TMS technology platform is highly likely to tap into a potentially vast medical device market.